1. Home
  2. DNUT vs VOR Comparison

DNUT vs VOR Comparison

Compare DNUT & VOR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Krispy Kreme Inc.

DNUT

Krispy Kreme Inc.

N/A

Current Price

$3.45

Market Cap

602.2M

ML Signal

N/A

Logo Vor Biopharma Inc.

VOR

Vor Biopharma Inc.

N/A

Current Price

$16.03

Market Cap

562.6M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
DNUT
VOR
Founded
1937
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Food Chains
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Staples
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
602.2M
562.6M
IPO Year
2021
2021

Fundamental Metrics

Financial Performance
Metric
DNUT
VOR
Price
$3.45
$16.03
Analyst Decision
Buy
Buy
Analyst Count
6
10
Target Price
$4.72
$64.78
AVG Volume (30 Days)
2.4M
618.2K
Earning Date
05-25-2026
01-01-0001
Dividend Yield
1.00%
N/A
EPS Growth
N/A
2.86
EPS
N/A
N/A
Revenue
$1,522,616,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$6.58
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.58
$0.13
52 Week High
$5.92
$49.95

Technical Indicators

Market Signals
Indicator
DNUT
VOR
Relative Strength Index (RSI) 51.63 60.22
Support Level $3.11 $11.27
Resistance Level $3.48 $16.95
Average True Range (ATR) 0.19 1.14
MACD 0.05 0.09
Stochastic Oscillator 43.50 75.99

Price Performance

Historical Comparison
DNUT
VOR

About DNUT Krispy Kreme Inc.

Krispy Kreme Inc is a sweet treat brand company. The company's Original Glazed doughnut is recognized for its hot-off-the-line, melt-in-your-mouth experience. It operates through its network of fresh Doughnut Shops, partnerships with retailers, and a growing e-commerce and delivery business. The company conducts its business through the following three reported segments: U.S., which includes all operations in the United States; International, which includes operations in the U.K., Ireland, Australia, New Zealand, Canada, Japan, and Mexico; and Market Development, which includes franchise operations across the globe. It derives maximum revenue from the U.S. segment.

About VOR Vor Biopharma Inc.

Vor Biopharma Inc is a clinical stage cell therapy company. It combines a novel patient engineering approach with targeted therapies to provide a solution for patients suffering from hematological malignancies. The company's products include VCAR33, Tremcel and Myelodysplastic Syndrome, Trem-cel+VCAR33 Treatment System, VADC45, CD123, CLL1, EMR2.

Share on Social Networks: